Simon Read
Director at Dianthus Therapeutics, Inc. /DE/ (DNTH)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $631K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Aug 19SEC | DNTHDianthus Therapeutics, Inc. /DE/ | Sell Plan | 2,778 | $117.55 | $327K | -29.9% |
| Aug 11SEC | DNTHDianthus Therapeutics, Inc. /DE/ | Sell Plan | 702,707 held (−3%) | $107.11 | $7K | -23.1% |
| Aug 11SEC | DNTHDianthus Therapeutics, Inc. /DE/ | Sell Plan | 7371,970 held (−27%) | $108.17 | $80K | -23.9% |
| Aug 11SEC | DNTHDianthus Therapeutics, Inc. /DE/ | Sell Plan | 8311,139 held (−42%) | $108.95 | $91K | -24.4% |
| Aug 11SEC | DNTHDianthus Therapeutics, Inc. /DE/ | Sell Plan | 272867 held (−24%) | $109.96 | $30K | -25.1% |
| Aug 11SEC | DNTHDianthus Therapeutics, Inc. /DE/ | Sell Plan | 470397 held (−54%) | $111.05 | $52K | -25.8% |
| Aug 11SEC | DNTHDianthus Therapeutics, Inc. /DE/ | Sell Plan | 397 | $111.77 | $44K | -26.3% |
- Sell
Director Simon Read sold $327K of DNTH at $117.55 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Simon Read sold $7K of DNTH at $107.11 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Simon Read sold $80K of DNTH at $108.17 — cuts the stake by 27%; pre-scheduled 10b5-1 plan sale.
- Sell
Director Simon Read sold $91K of DNTH at $108.95 — cuts the stake by 42%; pre-scheduled 10b5-1 plan sale.
- Sell
Director Simon Read sold $30K of DNTH at $109.96 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Simon Read sold $52K of DNTH at $111.05 — cuts the stake by 54%; pre-scheduled 10b5-1 plan sale.